Deputy Chairman & Senior Advisor of ChemoMetec Hans Glensbjerg Buys 15% More Shares

Potential ChemoMetec A/S (CPH:CHEMM) shareholders may wish to note that the Deputy Chairman & Senior Advisor, Hans Glensbjerg, recently bought kr.3.2m worth of stock, paying kr.456 for each share. That's a very decent purchase to our minds and it grew their holding by a solid 15%.

Check out our latest analysis for ChemoMetec

The Last 12 Months Of Insider Transactions At ChemoMetec

In fact, the recent purchase by Hans Glensbjerg was the biggest purchase of ChemoMetec shares made by an insider individual in the last twelve months, according to our records. That means that an insider was happy to buy shares at around the current price of kr.473. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. While we always like to see insider buying, it's less meaningful if the purchases were made at much lower prices, as the opportunity they saw may have passed. The good news for ChemoMetec share holders is that insiders were buying at near the current price.

ChemoMetec insiders may have bought shares in the last year, but they didn't sell any. They paid about kr.405 on average. It is certainly positive to see that insiders have invested their own money in the company. However, you should keep in mind that they bought when the share price was meaningfully below today's levels. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!

ChemoMetec is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket.

Insider Ownership

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. We usually like to see fairly high levels of insider ownership. From looking at our data, insiders own kr.25m worth of ChemoMetec stock, about 0.3% of the company. We prefer to see high levels of insider ownership.

What Might The Insider Transactions At ChemoMetec Tell Us?

The recent insider purchase is heartening. And the longer term insider transactions also give us confidence. Given that insiders also own a fair bit of ChemoMetec we think they are probably pretty confident of a bright future. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. Every company has risks, and we've spotted 2 warning signs for ChemoMetec you should know about.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.